Pediatrix Medical (MD) Cash & Equivalents (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash & Equivalents data on file, last reported at $205.8 million in Q1 2026.

• Quarterly Cash & Equivalents rose 107.9% year-over-year to $205.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205.8 million (up 107.9% YoY) and the FY2025 annual result came in at $375.2 million, up 63.19% from the prior year.
• Cash & Equivalents slipped to $205.8 million in Q1 2026 per MD's latest filing, from $375.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $375.2 million in Q4 2025 and bottomed at $5.8 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $21.2 million (2023), against an average of $103.1 million.
• The widest annual swing landed in 2022, when Cash & Equivalents slumped 97.58%; it then soared 1137.53% in 2025.
• Tracing MD's Cash & Equivalents over 5 years: stood at $9.8 million in 2022, then surged by 645.7% to $73.3 million in 2023, then soared by 213.88% to $229.9 million in 2024, then jumped by 63.19% to $375.2 million in 2025, then plunged by 45.16% to $205.8 million in 2026.
• Per Business Quant, the three latest MD Cash & Equivalents figures stand at $205.8 million (Q1 2026), $375.2 million (Q4 2025), and $340.1 million (Q3 2025).

Peer Comparison